| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/10/2002 | US20020004497 Combination injection preparation |
| 01/10/2002 | US20020004486 Miticides, parasiticides; veterinary medicine |
| 01/10/2002 | US20020004481 Controlled release microencapsulated ngf formulation |
| 01/10/2002 | US20020004101 Drug coating with topcoat |
| 01/10/2002 | US20020004075 Anti-cancer extracts and pharmaceutical compositions and methods |
| 01/10/2002 | US20020004072 "composition providing a sustained release of l-histidine and methods of manufacture thereof" |
| 01/10/2002 | US20020004071 Rapid-melt semi-solid compositions, methods of making same and methods of using same |
| 01/10/2002 | US20020004070 Antineoplastic product, use and formulation thereof |
| 01/10/2002 | US20020004069 Discoloration-resistant vitamin composition |
| 01/10/2002 | US20020004068 Composition |
| 01/10/2002 | US20020004067 Coated, apertured container permeable to water that is only semi-permeable to a pharmaceutical agent in the container |
| 01/10/2002 | US20020004066 Transdermal drug patch with attached pocket for controlled heating device |
| 01/10/2002 | US20020004065 Compositions and methods to effect the release profile in the transdermal administration of active agents |
| 01/10/2002 | US20020004064 Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties |
| 01/10/2002 | US20020004063 Methods and apparatus for drug delivery involving phase changing formulations |
| 01/10/2002 | US20020004062 Novel pharmacotherapeutic process and composition for central nervous system disorders |
| 01/10/2002 | US20020004049 Tryptophan source from plants and uses therfor |
| 01/10/2002 | US20020004044 Methods for inducing the differentiation of monocytes into functional dendritic cells |
| 01/10/2002 | US20020003179 Forming a dispersion of solid particles of a milled substrate in a fluid carrier comprising providing large size milling media and small size milling media, a conglomerate of solid comprising a substrate to be milled, milling, separating |
| 01/10/2002 | US20020002973 Increasing libido in humans via acute testosterone administration |
| 01/10/2002 | DE10030345A1 Hochkonzentrierte stabile Meloxicamlösungen Highly concentrated stable meloxicam |
| 01/10/2002 | CA2414966A1 A pharmaceutical component based on human parathyroid hormone and a pharmaceutical composition for intranasal administration containing the component |
| 01/10/2002 | CA2413166A1 Acid-modified arabinogalactan protein composition |
| 01/10/2002 | CA2412761A1 A positive hydration method of preparing confectionery and the resulting product |
| 01/10/2002 | CA2412676A1 Anti-viral composition |
| 01/10/2002 | CA2410972A1 Compounds to treat alzheimer's disease |
| 01/10/2002 | CA2410680A1 Compounds to treat alzheimer's disease |
| 01/09/2002 | EP1170368A2 Immunization by inoculation of dna transcription unit |
| 01/09/2002 | EP1170275A2 Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application |
| 01/09/2002 | EP1170020A1 Patches for external use |
| 01/09/2002 | EP1170012A1 Cerebrovascular regeneration/reconstruction promoters and nerve tissue secondary degeneration inhibitors comprising ginsenoside rb 1? |
| 01/09/2002 | EP1170006A1 Drugs for relieving hemicrania |
| 01/09/2002 | EP1170005A1 Autonomic controlling agents |
| 01/09/2002 | EP1170004A1 Preparations for percutaneous absorption |
| 01/09/2002 | EP1170003A1 Self-emulsifying drug delivery system for fat-soluble drugs |
| 01/09/2002 | EP1169457A2 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 01/09/2002 | EP1169349A2 Highly purified gonadotropin compositions and process for preparing them |
| 01/09/2002 | EP1169340A1 Lantibiotic |
| 01/09/2002 | EP1169314A1 Crystalline base of citalopram |
| 01/09/2002 | EP1169244A2 Metering valve |
| 01/09/2002 | EP1169118A1 Method for coating and film-coating fine powders in a fluidised bed coating unit |
| 01/09/2002 | EP1169117A1 Process and apparatus for producing particles using a supercritical fluid |
| 01/09/2002 | EP1169065A1 Formulations for detecting asthma |
| 01/09/2002 | EP1169063A2 Treatment of intracellular infection |
| 01/09/2002 | EP1169062A2 Heat stable coated colloidal iron oxides |
| 01/09/2002 | EP1169053A1 Pulmonary administration of dry powder formulations for treating infertility |
| 01/09/2002 | EP1169050A1 Ocular treatment using cyclosporin-a derivatives |
| 01/09/2002 | EP1169046A1 Pulmonary delivery of protonated/acidified nucleic acids |
| 01/09/2002 | EP1169043A1 Use of estrogens and delta-gonadien-21-ol-3,20-diones |
| 01/09/2002 | EP1169039A2 Pharmaceutical formulation comprising amoxycillin |
| 01/09/2002 | EP1169032A1 Ketoprofen microgranules, method for preparing same and pharmaceutical compositions |
| 01/09/2002 | EP1169026A2 Use of ap-1 activators to treat glaucoma and ocular hypertension |
| 01/09/2002 | EP1169025A2 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
| 01/09/2002 | EP1169024A1 Pregelatinized starch in a controlled release formulation |
| 01/09/2002 | EP1169023A1 Solubilizing aids in powder form for solid pharmaceutical presentation forms |
| 01/09/2002 | EP1169022A1 Elegant film coating system |
| 01/09/2002 | EP1169021A1 Compositions and methods for treating lymphoma |
| 01/09/2002 | EP1169020A1 Lipid aggregate forming compositions and their uses |
| 01/09/2002 | EP1169019A1 Pharmaceutical aerosol formulation |
| 01/09/2002 | EP1168997A1 Vacuum assisted closure system with provision for introduction of agent |
| 01/09/2002 | EP1168934A1 Hydrogel-forming system with hydrophobic and hydrophilic components |
| 01/09/2002 | EP1168919A2 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion |
| 01/09/2002 | EP1052978B1 Encapsulation system with organic core and mineral cortex based on aluminium hydroxycarbonate and preparation method |
| 01/09/2002 | EP1049461B1 Use of topical preparations of glyceryl trinitrate and lanolin for the treatment of erectile dysfunction |
| 01/09/2002 | EP0984699A4 Method of inhibiting immune system destruction of transplanted viable cells |
| 01/09/2002 | EP0949909B1 Individually dosed foil-form presentation which decomposes rapidly on contact with liquid and contains an active substance, in particular an aromatic substance |
| 01/09/2002 | EP0804172B1 Controlled release potassium dosage form |
| 01/09/2002 | EP0785795B1 A pharmaceutical formulation comprising a growth hormone and valine |
| 01/09/2002 | EP0765151B1 Antibacterial oil-in-water emulsions |
| 01/09/2002 | EP0727978B1 Topical aromatic releasing compositions |
| 01/09/2002 | CN1330648A 4-aryloxindoles as inhibitor of JNK protein kinases |
| 01/09/2002 | CN1330567A Microemulsions containing water and hydrofluoroethers |
| 01/09/2002 | CN1330551A Pharmaceutical formulation of Didemnin compound |
| 01/09/2002 | CN1330548A Phospholipid complexes of proanthocyanidin A2 used as antiatherosclerotic agents |
| 01/09/2002 | CN1330547A Pharmaceutical formulations |
| 01/09/2002 | CN1330546A Compositions comprising cefuroxime axetil |
| 01/09/2002 | CN1330543A Compositions and methods for amelioration of human female sexual dysfunction |
| 01/09/2002 | CN1330539A Compositions and methods for treatment of anorectal disorders |
| 01/09/2002 | CN1330538A Stable pharmaceutical formulation comprising HMC-CoA reductase inhibitor |
| 01/09/2002 | CN1330537A Pharmaceutical mixed comprising profen |
| 01/09/2002 | CN1330536A Biodegradable polymer encapsulated 5-hydroxytryptamine receptor antagonist and method for preparing the same |
| 01/09/2002 | CN1330532A Oil-in-water emulsion comprising micronised biologically active agent and appropriate emulsified system |
| 01/09/2002 | CN1330516A Improved of chewing gum containing medicament active agents release |
| 01/09/2002 | CN1329910A Chinese patent medicine 'Wuweibaigan wine (powder)' for treating gastrointestinal diseases |
| 01/09/2002 | CN1329901A Exterior-applied black plaster for treating bone diseases and its preparing process |
| 01/09/2002 | CN1329898A Medical plaster for treating condensing osteoarthropathy |
| 01/09/2002 | CN1329895A Exterior-applied ointment for treating hyperosteogeny |
| 01/09/2002 | CN1329890A Dual-layer slow releasing tablet of benproperine phosphate |
| 01/09/2002 | CN1329889A Concentrated granular medicine for treating baby cold and preparation process thereof |
| 01/09/2002 | CN1329886A Medical percutaneous preparation containing hydrophilic or salt form |
| 01/09/2002 | CN1329885A Preparing process and application of clam lipoid |
| 01/09/2002 | CN1077436C Anrutong capsule for treatment of mammary-gland disease |
| 01/09/2002 | CN1077435C Medicine for treating trachitis and preparation method thereof |
| 01/09/2002 | CN1077434C Chinese medicinal powder for treating toothache and preparation method thereof |
| 01/09/2002 | CN1077433C Method for preparing Bazhen sugarless elutuary |
| 01/09/2002 | CN1077429C Preparation for epidermis and process for its preparation |
| 01/09/2002 | CN1077427C Skin protecting composition containing acid hydrophilic agent for cosmetic use and application of same |
| 01/08/2002 | US6337348 Inhibiting motility of sperm with oxovanadium compound with 1,10-phenanthroline, 2,2'bipyridine, 2'hydroxyacetophenone or 3-hydroxypropenal for complexes |
| 01/08/2002 | US6337337 Methods for treating disorders responsive to DHFR-inhibition |
| 01/08/2002 | US6337329 Vision defects and antiinflammatory agents |